- This event has passed.
Post-AASLD
December 5 @ 6:00 pm - 9:00 pm
December 5, 2023
6:00-9:00 p.m. EST
Virtual CME Program
The Community Liver Alliance is planning its 10th Annual Post-AASLD Program led by Course Directors Michael Babich, MD with Allegheny Health Network and Karen Krok, MD FAASLD with Penn State Health Milton S. Hershey Medical Center.
We invite you to register for the CME program and share it with others to join us in this important educational initiative. Please use this link for registration:
Program Overview
The goal of the CME program is to learn more about current trends, management techniques, recent innovations, and research to treat a full range of liver conditions, including Fatty Liver/NASH, Hepatocellular Carcinoma, Cholestatic Diseases, and Liver Transplantation. The American Association for the Study of Liver Diseases (AASLD) is the leading organization of scientists and healthcare professionals committed to preventing and curing liver disease. The AASLD fosters research that leads to improved treatment options for millions of liver disease patients. They advance the science and practice of hepatology through educational conferences, training programs, professional publications, and partnerships with government agencies and sister societies. Each November, the AASLD holds the Annual Liver Meeting to provide access and education to groundbreaking science, the exchange of ideas with leading clinicians and researchers, and network with peers.
Who Should Attend?
This course is designed for providers in hepatology, gastroenterology, and abdominal and general surgery, referring primary care physicians, and other health care professionals with an interest in the treatment and latest research for liver disease.
Review Learning Objectives with Course Directors
At course completion, attendees should be able to:
- Identify advancements in non-alcoholic and alcoholic liver disease treatments, with attention to liver diseases such as NAFLD, cholestatic diseases, hepatocellular carcinoma, and viral hepatitis.
- Address barriers to liver transplantation and living-donor liver transplant, leading to enhanced patient care.
- Foster the development of multidisciplinary and interactive models to treat liver diseases.
- Partner with other regional academic liver programs and regional nonprofit collaborators to educate the regional medical community about liver disease advancements.
*** Industry partners must have an exhibit or sponsorship to participate in the Community Liver Alliance programs and events.
Your support allows the Community Liver Alliance to continue to provide education, resources and support to the liver community we all serve.
For more information on ways to support and collaborate with the Community Liver Alliance, please contact Suzanna Masartis at Suzanna@communityliveralliance.org or 412-400-9343.
Program Sponsors:
